They accuse Google of taking advantage of advertising for fake drugs against dementia


The digital giant Google has obtained cash advertising supplements against dementia, whose effectiveness has not been proven, thus benefiting from false hopes to people suffering from this disease, the newspaper said on March 25.

The British newspaper reports that the ads appeared when a user searched with word combinations like "Alzheimer's pills" or "dementia supplements" and were approved by Google's policies, which theoretically ensure that their advertising is "Safe and suitable for all"

Dementia is a generic syndrome that encompasses several neurological diseases. Besides being predominantly irreversiblemany forms of dementia are progressive, that is, they become worse over time.

According to WHO assessments, there are about 47 million people with dementia in the world, a number that will triple by 2050.

"No supplement A known dietary supplement prevents cognitive decline or dementia, "says Joanna Hellmuth, a physician at the University of California, San Francisco, in an interview with The Times.

However, Hellmuth discovered that the industry that promotes supplements against this syndrome moves $ 3.2 billion.

A dose of Souvenaid, one of the counterfeit drugs released by Google and dismissed by clinical trials as inefficient, costs about $ 4.6 a day, The Times reports. The company's spokeswoman, Nutricia,we announced the add-on on Google.

At the same time, the newspaper reports, referring to a statement from a Google spokesman, that the search engine has already removed the ads.of drugs against dementia.

"We have strict policies that determine the type of ads we allow on our platform, and ads for products that offer" miracle cures "for medical conditions are a violation of these policies," Google spokesman Citing.

Last week, the EU imposed a record antitrust fine on the digital giant for $ 1.7 billion. The total historical antitrust fines against the company in Europe was $ 9.3 billion.


Source link